"Don’t indiscriminately pay up, but extremely selectively do pay up as huge outliers will more than pay for the losses in the AI field!" @vkhosla.bsky.social on AI valuations today: www.theinformation.com/articles/ai-...

Congrats to Basis, Lead, Loyal and Rogo! Thrilled to be early into your journeys! www.forbes.com/sites/amyfel...

Regulatory frameworks should keep up with science, not slow it down. KV's Ness Bermingham talks about the opportunity to modernize the FDA for an era of personalized medicine👇 thehill.com/opinion/heal...

Welcome to KV, Mach Industries! 🚀 More from TechCrunch 👇 techcrunch.com/2025/06/17/t...

ICYMI - Kanu Gulati at @techcrunch.com Sessions on what to look for in early stage founders “I want to understand what can be demonstrable in the next three years vs. what’s still hype." techcrunch.com/video/cut-th...

Thrilled to see KV-backed innovation shaping the future on this year’s CNBC #Disruptor50 list. Huge congrats to all the teams! 🥳 www.cnbc.com/2025/06/10/2...

Forecasting weather with AI. Reimagining sweeteners with protein. Detecting colorectal cancer through a blood test. Excited to see KV-backed Windborne, Oobli and Guardant Health featured on @fastcompany’s World Changing Ideas 2025 list! 🌎✨ www.fastcompany.com/world-changi...

KV Summit 2025… racing to utopia!

20 years of building and beyond

Welcome to the KV portfolio, ClickHouse! 🎉 Powering lightning-fast, real-time analytics for the AI era. More here 👇 www.bloomberg.com/news/article...

Traditional cell therapies are expensive, slow to develop, and difficult to scale. Somite AI is building foundation models that systematically solve these challenges, with the potential to not only develop their own pipeline, but reshape the entire field of human cell therapy.

We've backed Realta Fusion since seed because of their unique SMR (small modular reactors) approach to fusion. It's a radically different model that unlocks scalable fusion energy from 50MW to 500MW with multiple paths to market for heat and electricity.

Excited to finally announce what Stylus Medicine is building to solve some of the biggest challenges in cell and gene therapies. Proud to have backed them since day one. Bold. Early. Impactful.

"Behind every great company, there was a prescient early investor who planted the seed that helped it grow into a redwood. For Facebook, that investor was Peter Thiel. For DoorDash and Opendoor, it was Keith Rabois."

Thrilled to join you on this adventure, Fastino! 🦊 techcrunch.com/2025/05/07/f...

NewLimit has raised a $130M Series B led by Kleiner Perkins alongside NFDG, @khoslaventures.bsky.social, Human Capital and returning investors Dimension & Founders Fund We're grateful for their boldness in joining us on our journey to extend human healthspan blog.newlimit.com/p/newlimit-r...

Congrats to Alice Brooks on @SFBusinessTimes 40 under 40! "I get to work with entrepreneurs solving the world's toughest problems: unlocking limitless fusion energy, growing more scalable sources of protein, creating high-performing circular materials and chemicals and more."

"If you need power now, you can't wait for the grid and you can't wait for natural gas turbines to come online." Samir Kaul With AI driving unprecedented energy demand, Mainspring’s fuel-flexible generators are key to scalable, distributed power. First check in!⚡ www.bloomberg.com/news/article...

A must watch for changemakers anywhere! KV portfolio founder Jackie Reses on disrupting fintech with Lead, lessons from Block and building company culture. youtu.be/pc19ZyZUZkQ?...

We are excited to be partnering with Halle and her team at Respin as they take on the large market of menopause and wellness. fortune.com/well/2025/02...

Today 75% of Traba's customers are asking about legal work authorization, compared to <5% just a few months ago. Keith Rabois and Mike Shebat talk about helping companies secure their workforces with Liz Claman👇 www.foxbusiness.com/video/636866...

Sci-fi becomes reality: Almost 10 yrs ago we backed eGenesis to solve the global organ shortage by genetically modifying pig organs for humans. Today they announced a second patient received one of their pig kidneys.

AI + cancer: C the Signs is using AI to detect cancer early! More from @wsj.com here: www.wsj.com/articles/kho...

Thrilled to back Atomicwork, a SaaS startup using AI agents to streamline communication & service delivery between employees and enterprises. 🚀 Read more from TechCrunch 👇 techcrunch.com/2025/01/28/a...

Bringing healthcare changemakers together!🌟 Our annual JPM reception yesterday brought together experts, innovators, and visionaries driving the future of healthcare.

Ask better questions: It’s not about how good a technology is today but how quickly it continues to improve. @vkhosla.bsky.social on the “rate of change” happening at OpenAI that led him to invest back in 2019. More in the latest from Steve Rosenbush www.wsj.com/articles/the...

Exciting news from Ultima Genomics! Another step closer to unlocking the power of genomics at scale 🧬 www.prnewswire.com/news-release...

Is the world ready for the transformational power of fusion? @vkhosla.bsky.social and Bob Mumgaard on how fusion energy, once a distant dream, is on the verge of becoming a reality www.weforum.org/stories/2025...

A huge moment for @cfs.energy and an important milestone for our energy future! We have been on this journey since 2018 and look forward to what's next from Bob Mumgaard and team.

Hi 👋 KV is now on @bsky.app Follow us for the latest on our portfolio companies, team and more.